Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model

Transplantation

Volumn 63, Issue 4, 1997, Pages 528-532

  King, Melissa B ^a,b   Jessurun, Jose ^a   Savik, S Kay ^a   Murray, Joel J ^a   Hertz, Marshall I ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Div Pulmon and Critical Care Med   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FIBROSIS; GRAFT REJECTION; HISTOINCOMPATIBILITY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRACHEITIS; XENOTRANSPLANTATION;

ANIMALS; BRONCHIOLITIS OBLITERANS; CYCLOSPORINE; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; TRACHEA;

EID: 0031048007     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702270-00007     Document Type: Article

References (17)

1. Cooper JD, Patterson GA, Trulock EP, et al. Results of single and bilateral lung transplantation in 131 consecutive recipients. J Thorac Cardiovasc Surg 1994; 107: 460.
2. King MB, Kshettry V, Bolman RM, Gross CR, Savik K, Hertz MI. Outcomes after lung transplantation based on pre-transplant diagnosis. Am Rev Respir Dis 1995; 151: A88.
3. Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993; 14: 751.
4. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
5. Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52: 306.
6. Uyama T, Winter JB, Groen G, Wildevuur CRH, Monden Y, Prop J. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 1992; 54: 809.
7. Al-Dossari GA, Kshettry VR, Jessurun J, Bolman RM. Experimental large animal model of obliterative bronchiolitis after lung transplantation. Ann Thorac Surg 1994; 58: 34.
8. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993; 142: 1945.
9. Harmon KR, Hertz MI. Immune suppression: background and considerations in lung transplantation. In: Patterson A, Couraud L, eds. Current topics in general thoracic surgery -lung transplantation. New York: Elsevier Publishing Co., 1994.
10. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16: 911.
11. Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol 1988; 19: 1403.
12. Romaniuk A, Prop JM, Petersen AH, Wildevuur CRH, Nieuwenhuis P. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation 1987; 44: 209.
13. Prop J, Romaniuk A, Petersen AH, Nieuwenhuis P, Wildevuur CRH. Bronchial epithelium of lung allografts expressing class II MHC antigens during acute rejection and after cyclosporine treatment. J Heart Transplant 1985; 4: 607.
14. Daly RC, McGregor CGA. Routine immediate direct bronchial artery revascularization for single lung transplantation. Ann Thorac Surgery 1994; 57: 1446.
15. Yousem SA, Paradis IL, Dauber JA, et al. Large airway inflammation in heart-lung transplant recipients - its significance and prognostic implications. Transplantation 1990; 49(3): 654.
16. Loubeyre P, Revel D, Delignette A, et al. Bronchiectasis detected with thin section CT as a predictor of chronic lung allograft rejection. Radiology 1995; 194: 213.
17. Al-Dossari GA, Jessurun J, Bolman RM, et al. Pathogenesis of obliterative bronchiolitis: possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 1995; 59: 143.